Crossed looks on lung cancer perception and knowledge from general public and physicians in France: Results of a two-fold survey
Mascaux, C., Sauvajeon, S., Cadranel, J., Chouaid, C., Stern, J.B., Vergnenegre, A., Cortot, C., Guery, L., Belkhiria, K., De la Porte, I., Urbieta, M., Perol, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1650P - Crossed looks on lung cancer perception and knowledge from general public and physicians in France: Results of a two-fold survey
Mascaux, C., Sauvajeon, S., Cadranel, J., Chouaid, C., Stern, J.B., Vergnenegre, A., Cortot, C., Guery, L., Belkhiria, K., De la Porte, I., Urbieta, M., Perol, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1650PCrossed looks on lung cancer perception and knowledge from general public and physicians in France: Results of a two-fold survey
Mascaux, C, Sauvajeon, S, Cadranel, J, Chouaid, C, Stern, J B, Vergnenegre, A, Cortot, C, Guery, L, Belkhiria, K, De la Porte, I, Urbieta, M, Perol, M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1470PFirst real life data on durvalumab after definitive concomitant chemoradiotherapy (cCRT) in unresectable stage (St) III non-small cell lung cancer (NSCLC) in France: Analysis of 591 patients (pts) enrolled in the French cohort (c) temporary authorization of use (ATU)
Avrillon, V, Bota Ouchlif, S, Merle, P, Pichon, E, Stancu, A T, Chouaid, C, Sire, C, Boudabous, H, Lagrange, A, Sabatini, M, Eberst, G, Boisselier, P, Gourion, A, Lion, A, Lahouegue, A, Belkhiria, K, de La Porte, I, Urbieta, M, Mornex, F, Girard, N
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
First real life data on durvalumab after definitive concomitant chemoradiotherapy (cCRT) in unresectable stage (St) III non-small cell lung cancer (NSCLC) in France: Analysis of 591 patients (pts) enrolled in the French cohort (c) temporary authorization of use (ATU)
Avrillon, V., Bota Ouchlif, S., Merle, P., Pichon, E., Stancu, A.T., Chouaid, C., Sire, C., Boudabous, H., Lagrange, A., Sabatini, M., Eberst, G., Boisselier, P., Gourion, A., Lion, A., Lahouegue, A., Belkhiria, K., de La Porte, I., Urbieta, M., Mornex, F., Girard, N.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1470P - First real life data on durvalumab after definitive concomitant chemoradiotherapy (cCRT) in unresectable stage (St) III non-small cell lung cancer (NSCLC) in France: Analysis of 591 patients (pts) enrolled in the French cohort (c) temporary authorization of use (ATU)
Avrillon, V., Bota Ouchlif, S., Merle, P., Pichon, E., Stancu, A.T., Chouaid, C., Sire, C., Boudabous, H., Lagrange, A., Sabatini, M., Eberst, G., Boisselier, P., Gourion, A., Lion, A., Lahouegue, A., Belkhiria, K., de La Porte, I., Urbieta, M., Mornex, F., Girard, N.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
2755 First real life data on Olaparib in BRCA1/2 mutated Platinum-Sensitive Relapsed (PSR) Epithelial Ovarian Cancer (EOC) in France: Analysis of 52 patients (pts) enrolled in the French Temporary Authorization for Use (ATU)
De La Motte Rouge, T, Pautier, P, Alexandre, J, Ray-Coquard, I, Cottu, P, Rodrigues, M, Follana, P, Floquet, A, Lortholary, A, Heudel, P.E, Combe, P, Joly, F, Suau, D, Maribas, D, Licour, M, Porte, I. De La, Varoqueaux, N, Pujade-Lauraine, E
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article